Return to Activity After Surgery for Lumbar Disc Herniation
1 other identifier
interventional
120
1 country
1
Brief Summary
RCT investigating postoperative activity restriction after lumbar discectomy in patients treated with annular closure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedStudy Start
First participant enrolled
June 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2027
June 25, 2026
June 1, 2026
1.3 years
June 18, 2026
June 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptomatic reherniation
No symptomatic reherniation at the index level (on either side)
3 Months
Study Arms (2)
Non restricted postoperative instructions
EXPERIMENTALNon restricted postoperative instructions
Restricted postoperative instructions
ACTIVE COMPARATORRestricted postoperative instructions
Interventions
Investigating different postoperative restrictions after lumbar disc herniation surgery
Eligibility Criteria
You may qualify if:
- Skeletally mature (male or female).
- Patients with posterior or posterolateral disc herniations at one level between L4 and S1 with radiographic confirmation of neural compression using MRI. \[Note: Intraoperatively, only patients with an annular defect (post discectomy) between 4mm and 6mm tall and 6mm and 10mm wide shall qualify.\]
- Minimum posterior disc height of 5mm at the index level.
- Radiculopathy (with or without back pain) with a positive Straight Leg Raise (0 - 60 degrees)22 (L45, L5S1)
- VAS leg pain (one or both legs) of at least 40/100 at baseline
- Psychosocially, mentally and physically able to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements.
- Implanted with annular closure device.
You may not qualify if:
- Spondylolisthesis Grade II or higher (25% slip or greater).
- Subject requires spinal surgery other than a discectomy (with or without laminotomy) to treat leg/back pain (scar tissue and osteophyte removal is allowed).
- Subject has been diagnosed with active hepatitis, AIDS, or HIV.
- Subject has been diagnosed with rheumatoid arthritis or other autoimmune disease.
- Subject has a known allergy to titanium, polyethylene or polyester materials.
- Any subject that cannot have a baseline MRI taken.
- Subject is pregnant or interested in becoming pregnant in the next year.
- Subject has active tuberculosis or has had tuberculosis in the past three (3) years.
- Subject has a history of active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer), unless he/she has been treated with curative intent and there have been no signs or symptoms of the malignancy for at least two (2) years.
- Subject is immunologically suppressed, received steroids \>1 month over the past year.
- Currently taking anticoagulants, other than aspirin, unless the patient can be taken off the anticoagulant for surgery.
- Subject has a current chemical/alcohol dependency or significant psychosocial disturbance.
- Subject has a life expectancy of less than three (3) years.
- Subject is currently involved in active spinal litigation (Workers' compensation patients may be included.
- Subject is currently involved in another investigational study.
- +14 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Spine Institute of Louisiana
Shreveport, Louisiana, 71101, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
David H Kim, MD
Atrius Health
Central Study Contacts
Kelsey Miller-Torchia A SVP, Clinical & Business Development, BA
CONTACT
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2026
First Posted
June 25, 2026
Study Start
June 30, 2026
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 31, 2027
Last Updated
June 25, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
No external collaboration expected